Here are four points:
1. CG Asset Management owns around 0.11 percent of NuVasive, worth $2.9 million.
2. NuVasive has a 50-day moving average of $42.88 and a 200-day moving average of $49.16.
3. The company has a 12-month low of $36.81 and a 12-month high of $56.61.
4. The company has a market cap of $2.34 billion.
More articles on devices:
28 orthopedic & spine devices receive FDA 510(k) clearance in February
Medtech sells 3 ROSA Brain Systems in US, China — 4 points
Mayo Clinic researchers develop expandable polymer grafts — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
